In the subset of OSA patients who were receiving statin therapy, the percentage of total CD59 located on the plasma membrane was similar to controls and significantly greater than in their OSA counterparts who were not taking statins (P = 0.05), suggesting that statins preserve CD59 on the EC plasma membrane in OSA (Fig. 5A). This evidence concerns the gene CD59 and obstructive sleep apnea syndrome.